Arcadi Liti (NYSE:ALTM) rose 0.4% amid a report on pending approvals for its planned $6.7 billion sale to Rio Tinto.
The two latest regulatory approvals of Australia’s Foreign Investment Review Board and the Investment Canada Act are
Arcadi Liti (NYSE:ALTM) rose 0.4% amid a report on pending approvals for its planned $6.7 billion sale to Rio Tinto.
The two latest regulatory approvals of Australia’s Foreign Investment Review Board and the Investment Canada Act are
Stargate isn’t just a big investment in AI — it’s a high-stakes bet on technology, power, and future global dominance. Read More Source link
James Kelleher, CFA Director of Research and Senior Technology Analyst Jim has worked in the financial services industry for over 25 years and joined Argus in 1993. He is Argus’…